Friedberg Ezra M Insider Profile
4 Followers
Friedberg Ezra M, Director at Pelthos Therapeutics, holds 203.11K shares in Pelthos Therapeutics (Ticker: PTHS), holds ― shares in Humanigen (Ticker: HGENQ).
Friedberg Ezra M Pelthos Therapeutics (PTHS)Director
Pelthos Therapeutics (PTHS)
Director
Ranked #33,943 out of 109,030 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+49.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Friedberg Ezra M's holdings
Insider Roles
Director
Roles that Friedberg Ezra M holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 03, 2025 - Jul 03, 2026
Return:+76.00%
The most profitable trade made by Friedberg Ezra M
Friedberg Ezra M's Trading History
Pelthos Therapeutics
Jul 07, 2026
Director
Uninformative Sell
14.56K
$4.60M
Humanigen
―
―
―
―
List of latest transactions for each holding click on a transaction to see Friedberg Ezra M's performance on stock
You May Also Like
Friedberg Ezra M insider profile FAQ
What is the percentage of profitable transactions made by Friedberg Ezra M?
The percentage of profitable transactions made by Friedberg Ezra M is 100%.
What is the average return per transaction made by Friedberg Ezra M?
The average return per transaction made by Friedberg Ezra M is 49.50%.
What stocks does Friedberg Ezra M hold?
Friedberg Ezra M holds: PTHS, HGENQ stocks.
What was Friedberg Ezra M’s latest transaction?
Friedberg Ezra M latest transaction was an Uninformative Sell of $14.56K.
What was Friedberg Ezra M's most profitable transaction?
Friedberg Ezra M’s most profitable transaction was an Informative Buy of PTHS stock on July 3, 2025. The return on the trade was 76.00%.
What is Friedberg Ezra M's role in Pelthos Therapeutics?
Friedberg Ezra M's role in Pelthos Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.